These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28848923)

  • 41. Airway clearance techniques for chronic obstructive pulmonary disease.
    Osadnik CR; McDonald CF; Jones AP; Holland AE
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008328. PubMed ID: 22419331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Kida K
    J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One-year change in health status and subsequent outcomes in COPD.
    Wilke S; Jones PW; Müllerova H; Vestbo J; Tal-Singer R; Franssen FM; Agusti A; Bakke P; Calverley PM; Coxson HO; Crim C; Edwards LD; Lomas DA; MacNee W; Rennard SI; Yates JC; Wouters EF; Spruit MA
    Thorax; 2015 May; 70(5):420-5. PubMed ID: 25782757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease.
    Suzuki A; Kondoh Y; Swigris JJ; Ando M; Kimura T; Kataoka K; Yamano Y; Furukawa T; Numata M; Sakamoto K; Hasegawa Y
    Respirology; 2018 Mar; ():. PubMed ID: 29575410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes following first short-term clinically important deterioration in COPD.
    Naya IP; Tombs L; Muellerova H; Compton C; Jones PW
    Respir Res; 2018 Nov; 19(1):222. PubMed ID: 30453972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of health-related quality of life worsening in patients with chronic obstructive pulmonary disease at one year.
    Liang L; Lin Y; Yang T; Zhang H; Li J; Wang C
    Chin Med J (Engl); 2014; 127(1):4-10. PubMed ID: 24384416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of hospitalizations due to exacerbations or spontaneous pneumothoraxes on the quality of life, mental function and symptoms of depression and anxiety in patients with COPD or asthma.
    Filipowski M; Bozek A; Kozlowska R; Czyżewski D; Jarzab J
    J Asthma; 2014 Apr; 51(3):294-8. PubMed ID: 24188733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
    Donohue JF; Jones PW; Bartels C; Marvel J; D'Andrea P; Banerji D; Morris DG; Patalano F; Fogel R
    Pulm Pharmacol Ther; 2018 Apr; 49():11-19. PubMed ID: 29277690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
    Kusunose M; Oga T; Nakamura S; Hasegawa Y; Nishimura K
    BMJ Open Respir Res; 2017; 4(1):e000196. PubMed ID: 28883929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of the Airway Questionnaire 20 to detect changes in quality of life in asthmatic patients and its association with the St George's Respiratory Questionnaire and clinical parameters.
    Win T; Pearce L; Nathan J; Cafferty F; Laroche C
    Can Respir J; 2008 Apr; 15(3):133-7. PubMed ID: 18437255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.
    Nishimura K; Nakamura S; Kusunose M; Nakayasu K; Sanda R; Hasegawa Y; Oga T
    BMJ Open Respir Res; 2018; 5(1):e000305. PubMed ID: 30397483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study.
    Chan HP; Mukhopadhyay A; Chong PL; Chin S; Wong XY; Ong V; Chan YH; Lim TK; Phua J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():823-9. PubMed ID: 27217739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life.
    Camac ER; Stumpf NA; Voelker HK; Criner GJ
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):298-308. PubMed ID: 35397199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease.
    Mohsen S; Hanafy FZ; Fathy AA; El-Gilany AH
    Lung India; 2019; 36(3):193-198. PubMed ID: 31031337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.
    Mannino DM; Tal-Singer R; Lomas DA; Vestbo J; Graham Barr R; Tetzlaff K; Lowings M; Rennard SI; Snyder J; Goldman M; Martin UJ; Merrill D; Martin AL; Simeone JC; Fahrbach K; Murphy B; Leidy N; Miller B
    Chronic Obstr Pulm Dis; 2015; 2(1):23-34. PubMed ID: 25685850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.